© 2019 All rights reserved
In Visian ICL surgery, a biocompatible contact lens is placed inside the eye behind the colored iris to correct vision. The contact lens is made of Collamer material, which is collagen naturally found in the body and thus no rejection is encountered. Unlike corneal procedures, such as LASIK or SMILE, which corrects vision through corneal tissue removal, ICL is an additive procedure and does not alter the natural architecture of the eye. The advantages of ICL include highly accurate surgical outcomes even for individuals with high correction, the stability of vision without regression, and an option to undergo LASIK or other laser vision correction procedures at a future date. Furthermore, as ICL surgery does not involve cutting of the corneal nerves and is non-disruptive to corneal structure, patients do not experience dryness following surgery. ICL corrects nearsightedness with or without astigmatism. The patients who undergo ICL tend to have the highest rate of satisfaction.
The acceptance and popularity of the ICL procedure have grown over the years, and Dr. Paul C. Lee has been at the forefront each step of the way. As an early adopter since its approval in 2005, he is one of the most experienced ICL surgeons in the U.S. He was also the first surgeon on the West Coast to perform ICL with astigmatism procedure upon its FDA approval in 2018. His successes with ICL surgery was recognized when he was presented with the Top ICL Surgeon in the Nation Award.